Integer Holdings Names Payman Khales as COO, Andrew Senn as Cardio & Vascular President

• Integer Holdings appoints Payman Khales as COO in Q1 2025 • Khales moves from President, Cardio & Vascular role • Andrew Senn takes over Cardio & Vascular leadership • Khales to oversee Cardio & Vascular, CRM & Neuromodulation, and Global Ops • Focus on sharing best practices and improving execution speed

Integer Holdings Corporation (ITGR), a leading player in the medical device contract development and manufacturing sector, announced major leadership changes set to take effect in the first quarter of 2025. Payman Khales, who has excelled as the President of Cardio & Vascular, will assume the newly created role of Chief Operating Officer (COO), while Andrew Senn will step into the position of President, Cardio & Vascular [1].

Khales, who joined Integer in early 2018, has demonstrated remarkable leadership and strategic vision. During his tenure as President of Cardio & Vascular, he spearheaded significant growth within this segment, achieving above-market sales and enhancing market penetration [1]. In his new role as COO, Khales will oversee both of Integer's primary product categories—Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation—focusing on fostering best practices across divisions and streamlining global operations and manufacturing strategies [1].

CEO Joe Dziedzic praised Khales' exemplary leadership and strategic vision, noting his deep understanding of market dynamics and manufacturing processes positions him well for this expanded role [1]. Khales expressed enthusiasm for collaborating with his new peers to continue delivering high-quality, complex medical products while sustaining growth.

Andrew Senn, who has been with Integer for 18 years, including 15 years specifically in the Cardio & Vascular domain, brings a wealth of experience to his new role. Previously serving as Senior Vice President of Strategy, Business Development, and Investor Relations, Senn has a background in various functions such as research and development, program management, and marketing [1]. Dziedzic praised Senn's deep industry knowledge and customer-centric approach as essential assets for leading the Cardio & Vascular category.

Both executives' appointments signal Integer's commitment to strengthening its leadership team to drive innovation and expand its market presence in the medical device industry [1].

Sources:
[1] MarketWireNews. (2025, January 5). Payman Khales to Assume the Role of Integer Chief Operating Officer. Retrieved January 10, 2025, from https://marketwirenews.com/news-releases/payman-khales-to-assume-the-role-of-integer-chief-operating-officer-6150091613088390.html